Table 1.
Characteristics of prostate cancer patients
| Patient ID | Age | Diagnosis | Gleason Grade | PSA (μg/L), Preoperation | TNM | Surgery | Location |
|---|---|---|---|---|---|---|---|
| Pro # 1 | 68 | Adenocarcinoma | 5 | 6.2 | pT2cN1 | RALP | Prostata |
| Pro # 2 | 74 | Adenocarcinoma | 8 (4 + 4) | 9.2 | pT2a | RALP | Prostata |
| Pro # 3 | 58 | Adenocarcinoma | 7 (4 + 3) | 28.6 | pT3a | RALP | Prostata |
| Pro # 4 | 62 | Adenocarcinoma | 7 (3 + 4) | 7.6 | pT3bN0 | RALP | Prostata |
| Pro # 5 | 71 | Adenocarcinoma | 7 (3 + 4) | 6.9 | pT2c | RALP | Prostata |
PSA, prostate-specific antigen; RALP, robotic-assisted laparoscopic prostatectomy; TNM, pathological tumor-node metastasis.